Awareness of Individuals with Chronic Lung Disease About Climate Change, Heat Waves, Air Pollution and Physical Activity
NCT ID: NCT06592235
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
80 participants
OBSERVATIONAL
2024-09-01
2025-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Can Nursing Students' Knowledge and Attitudes Toward Climate Change
NCT07293845
Assessing Sustainable Behaviors and Health Impacts of Climate Change
NCT06290804
Physical Activity of Participants in Different Age Groups
NCT06622785
The Effect of Education Based on the Chronic Care Model in COPD Patients
NCT05029557
Climate Change Awareness: a Randomized Controlled Trial
NCT06905548
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Individuals with chronic obstructive lung disease
Individuals with chronic obstructive lung disease
No intervention
No intervention
Individuals with asthma
Individuals with asthma
No intervention
No intervention
Individuals with bronchiectasis
Individuals with bronchiectasis
No intervention
No intervention
Individuals with interstitial lung disease
Individuals with interstitial lung disease
No intervention
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having a chronic lung disease (COPD, asthma, bronchiectasis, cystic fibrosis, interstitial lung disease) and being referred to the Cardiopulmonary Rehabilitation Unit of Hacettepe University, Faculty of Physical Therapy and Rehabilitation for cardiopulmonary physiotherapy and rehabilitation,
* Being clinically stable,
* Using a smartphone with a pedometer,
* To cooperate with the tests to be conducted,
* Being willing to participate in the study.
Exclusion Criteria
* Having a severe cardiovascular, orthopedic or neurological problem that may affect the tests.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aslihan Cakmak
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aslihan Cakmak-Onal, PhD, PT
Role: PRINCIPAL_INVESTIGATOR
Hacettepe University
Naciye Vardar-Yagli, PhD, PT
Role: STUDY_DIRECTOR
Hacettepe University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacettepe University Faculty of Physical Therapy and Rehabilitation
Ankara, Ankara, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Aslihan Cakmak-Onal, PhD, PT
Role: backup
Naciye Vardar-Yagli, PhD, PT
Role: backup
Ziya Toros Selçuk, MD
Role: backup
Deniz İnal-İnce, PhD, PT
Role: backup
Melda Sağlam, PhD, PT
Role: backup
Ebru Çalık-Kütükcü, PhD, PT
Role: backup
Elif Kocaağa, MSc, PT
Role: backup
Aydan Aslı Aksel-Uylar, MSc, PT
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
D'Amato G, Cecchi L, D'Amato M, Annesi-Maesano I. Climate change and respiratory diseases. Eur Respir Rev. 2014 Jun;23(132):161-9. doi: 10.1183/09059180.00001714. No abstract available.
Ebi KL, Vanos J, Baldwin JW, Bell JE, Hondula DM, Errett NA, Hayes K, Reid CE, Saha S, Spector J, Berry P. Extreme Weather and Climate Change: Population Health and Health System Implications. Annu Rev Public Health. 2021 Apr 1;42:293-315. doi: 10.1146/annurev-publhealth-012420-105026. Epub 2021 Jan 6.
Tran HM, Tsai FJ, Lee YL, Chang JH, Chang LT, Chang TY, Chung KF, Kuo HP, Lee KY, Chuang KJ, Chuang HC. The impact of air pollution on respiratory diseases in an era of climate change: A review of the current evidence. Sci Total Environ. 2023 Nov 10;898:166340. doi: 10.1016/j.scitotenv.2023.166340. Epub 2023 Aug 15.
Eguiluz-Gracia I, Mathioudakis AG, Bartel S, Vijverberg SJH, Fuertes E, Comberiati P, Cai YS, Tomazic PV, Diamant Z, Vestbo J, Galan C, Hoffmann B. The need for clean air: The way air pollution and climate change affect allergic rhinitis and asthma. Allergy. 2020 Sep;75(9):2170-2184. doi: 10.1111/all.14177. Epub 2020 Jan 30.
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. doi: 10.1016/0021-9681(87)90171-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SBA 24/794
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.